This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Incyte Corporation, Macrogenics, Inc.. Active years: 2025.
Company Filing History:
1 out of 686 
1 out of 132 
Years Active: 2025
Title: Mark Cornfeld: Innovator in Cancer Treatment
Introduction
Mark Cornfeld is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer treatment through his innovative work on antibodies. His research focuses on the development of methods to treat cancer using specific antibodies that target PD-1.
Latest Patents
Cornfeld holds a patent for "Anti-PD-1 antibodies and uses thereof." This patent outlines methods of treatment for cancer utilizing antibodies and antibody fragments that bind to PD-1. His work in this area has the potential to impact cancer therapies significantly.
Career Highlights
Throughout his career, Mark Cornfeld has worked with prominent companies in the biotechnology sector. He has been associated with Incyte Corporation and Macrogenics, Inc., where he has contributed to advancing cancer treatment methodologies. His experience in these organizations has enriched his expertise in the field.
Collaborations
One of his notable collaborators is Jon Marc Wigginton. Their partnership has likely fostered innovative approaches to cancer treatment, although specific details of their collaboration are not provided.
Conclusion
Mark Cornfeld's contributions to cancer treatment through his patent on Anti-PD-1 antibodies exemplify his commitment to innovation in the medical field. His work continues to pave the way for advancements in cancer therapies.